share_log

HC Wainwright & Co. Maintains Buy on Blue Water Biotech, Raises Price Target to $9

HC Wainwright & Co. Maintains Buy on Blue Water Biotech, Raises Price Target to $9

HC Wainwright & Co.维持对蓝水生物技术的买入,将目标价上调至9美元
Benzinga ·  2023/04/26 10:37

HC Wainwright & Co. analyst Vernon Bernardino maintains Blue Water Biotech (NASDAQ:BWV) with a Buy and raises the price target from $7 to $9.

HC Wainwright & Co. 分析师弗农·贝纳迪诺维持蓝水生物技术(纳斯达克股票代码:BWV)的买入,并将目标股价从7美元上调至9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发